Neuroscience: Alzheimer's disease

Nature

Volumn 461, Issue 7266, 2009, Pages 895-897

  Mucke, Lennart ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; NEUROPROTECTIVE AGENT; TAURINE TRANSPORTER;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; ECHOENCEPHALOGRAPHY; HEREDITY; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION;

AGE OF ONSET; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CONTROLLED CLINICAL TRIALS AS TOPIC; GENETIC TESTING; HUMANS; MICE; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; UNITED STATES;

EID: 70350075694     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/461895a     Document Type: Note

References (6)

1. Alzheimer's Association 2009 Alzheimer's Disease Facts and Figures (2009).
2. Chin, J., Roberson, E. D. & Mucke, L. in Learning and Memory: A Comprehensive Reference Vol. 4 (ed. Byrne, J. H.) Ch. 15 (Academic, 2008).
3. Mahley, R. W., Weisgraber, K. H. & Huang, Y. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 5644-5651 (2006).
4. Roberson, E. D. & Mucke, L. 100 years and counting: Prospects for defeating Alzheimer's disease. Science 314, 781-784 (2006).
5. www.alzforum.org
6. w.clinicaltrials.gov